Health-related quality of life is often an endpoint in oncology clinical trials. The European Organization for Research and Treatment of Cancer (EORTC) developed the cancer-specific quality of life questionnaire (QLQ-C30), which includes five functions, nine symptoms, and a global health status. These questionnaires are completed by the patients themselves throughout the process of care. The recommended approaches for processing EORTC QLQ-C30 data are usually descriptive and graphic
We investigated the validity of the recently developed European Organisation for Research and Treatm...
Abstract Background The aim of this study was to compare the responsiveness of the European Organiza...
Background: The European Organization for Research and Treatment of Cancer (EORTC) QLQ- BR23 was one...
Aim The European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire Co...
Aim The European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire Co...
Quality of life (QL) is an important outcome in clinical trials in oncology. There is currently no v...
High-dose chemotherapy followed by haematopoietic stem cell transplantation can be associated with h...
AbstractThe impact of cancer on patients' lives can be measured using self-reported questionnaires, ...
AIM: To review reporting standard, presentation and interpretation for quality of life (QOL) outcome...
The European Organization for Research and Treatment of Cancer (EORTC) Quality of Life Study Group h...
There is overwhelming consensus that quality of life assessment is urgently required in pancreatic c...
The research about cancer patients’ quality of life on before and after therapy of high emetogenic c...
The research about cancer patients’ quality of life on before and after therapy of high emetogenic c...
Although cancer-specific Health-Related Quality of Life (HRQOL) are commonly included in randomized ...
Background: This review aims to assist cancer clinical researchers in choosing between the two most ...
We investigated the validity of the recently developed European Organisation for Research and Treatm...
Abstract Background The aim of this study was to compare the responsiveness of the European Organiza...
Background: The European Organization for Research and Treatment of Cancer (EORTC) QLQ- BR23 was one...
Aim The European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire Co...
Aim The European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire Co...
Quality of life (QL) is an important outcome in clinical trials in oncology. There is currently no v...
High-dose chemotherapy followed by haematopoietic stem cell transplantation can be associated with h...
AbstractThe impact of cancer on patients' lives can be measured using self-reported questionnaires, ...
AIM: To review reporting standard, presentation and interpretation for quality of life (QOL) outcome...
The European Organization for Research and Treatment of Cancer (EORTC) Quality of Life Study Group h...
There is overwhelming consensus that quality of life assessment is urgently required in pancreatic c...
The research about cancer patients’ quality of life on before and after therapy of high emetogenic c...
The research about cancer patients’ quality of life on before and after therapy of high emetogenic c...
Although cancer-specific Health-Related Quality of Life (HRQOL) are commonly included in randomized ...
Background: This review aims to assist cancer clinical researchers in choosing between the two most ...
We investigated the validity of the recently developed European Organisation for Research and Treatm...
Abstract Background The aim of this study was to compare the responsiveness of the European Organiza...
Background: The European Organization for Research and Treatment of Cancer (EORTC) QLQ- BR23 was one...